Literature DB >> 20586691

Sleep deprivation in depression.

Ulrich-Michael Hemmeter1, Julia Hemmeter-Spernal, Jürgen-Christian Krieg.   

Abstract

Sleep deprivation (SD) is a powerful antidepressant treatment that shows antidepressant responses within hours in 40-60% of depressed patients. In more than 80% of responders to SD, a relapse into depression occurred after the recovery night. In addition, it serves as an excellent tool to examine the neurobiological disturbance of depression and may profoundly contribute to the development of new specific and more rapidly acting antidepressants. The reason why SD works and relapses occur is still unclear. A key to solve this problem is to include the current knowledge about the neurobiological disturbance of depression in research, with a focus on neurobiological aspects of sleep and SD (sleep EEG, neuroendocrinology, neurochemistry and chronobiology). Based on findings from these different areas, different strategies to stabilize the antidepressant effect of SD have been applied. This article provides an overview of clinical and neurobiological responses related to SD in depression.

Entities:  

Mesh:

Year:  2010        PMID: 20586691     DOI: 10.1586/ern.10.83

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  29 in total

Review 1.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 2.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 3.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 4.  Astrocytic adenosine: from synapses to psychiatric disorders.

Authors:  Dustin J Hines; Philip G Haydon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-19       Impact factor: 6.237

5.  Prefrontal Cortex to Accumbens Projections in Sleep Regulation of Reward.

Authors:  Zheng Liu; Yao Wang; Li Cai; Yizhi Li; Bo Chen; Yan Dong; Yanhua H Huang
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

6.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

7.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

Review 8.  The cognitive cost of sleep lost.

Authors:  John G McCoy; Robert E Strecker
Journal:  Neurobiol Learn Mem       Date:  2011-08-22       Impact factor: 2.877

9.  Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain.

Authors:  David Elmenhorst; Eva-Maria Elmenhorst; Eva Hennecke; Tina Kroll; Andreas Matusch; Daniel Aeschbach; Andreas Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

10.  Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice.

Authors:  Basma Radwan; Dino Dvorak; André A Fenton
Journal:  Neurobiol Dis       Date:  2016-01-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.